Linshom Medical Announces FDA Clearance of the Company’s 2nd Generation Respiratory Sensor
Linshom Medical Completes Clinical Study Enrollment at The Ohio State University Wexner Medical Center
Linshom Medical Picked by TechConnect as Finalist in the Medical Threat Challenge
Linshom Medical Receives $100K MIPS Award and Launches Clinical Study with University of Maryland School of Medicine Faculty
Linshom Medical Chosen by the NIH for Sponsorship to Attend the Angel Capital Association Annual Meeting
TEDCO Announces SSBCI Investment in Linshom Medical
Linshom Medical, Inc. Closes $650K in Series A Round with Investments from Abell Foundation and TEDCO
Lighthouse Labs Announces Companies in Batch 15 for Fall 2023
Linshom Medical selected for MassChallenge 2023 Early-Stage Cohort
Linshom Medical Launches Clinical Study at Ohio State University Wexner Medical Center
TEDCO Invests in Linshom Medical
Linshom Medical awarded $2.4M SBIR Fasttrack award from NIH (NHLBI)
Linshom Medical Selected as Finalist in “Swim with the Sharks” Competition at the ASA National Meeting
ATI and TechConnect Announce first round of Medical Innovation Challenge Winners
Linshom Medical, Inc. Closes Series A Round Investment from Maryland Momentum Fund and Current Investors
Linshom Receives SBIR Phase II Contract Award from the United States Air Force for its Dual Purpose Respiratory Device
Linshom Medical Announces European Patent Coverage for the Linshom Continuous Respiratory Monitor
Linshom Medical Announces FDA Clearance of the Linshom Respiratory Monitoring Device
Sign up for important info about business with us and relevant product updates. Your email will never be shared or used for anything other than updates from us.
© 2024 Linshom Medical